Chang GC - Search Results

1

Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer.

Yang CH, Shih JY, Chen KC, Yu CJ, Yang TY, Lin CP, Su WP, Gow CH, Hsu C, Chang GC, Yang PC. Yang CH, et al. Among authors: chang gc. Cancer. 2006 Oct 15;107(8):1873-82. doi: 10.1002/cncr.22220. Cancer. 2006. PMID: 16989002 Free article.

2

Serial-measured versus estimated creatinine clearance in patients with non-small cell lung cancer receiving cisplatin-based chemotherapy.

Chang GC, Yang TY, Shih CM, Lin LY, Lee HS, Chiang CD. Chang GC, et al. J Formos Med Assoc. 2003 Apr;102(4):257-61. J Formos Med Assoc. 2003. PMID: 12833190

3

Successful treatment of multifocal bronchioloalveolar cell carcinoma with ZD1839 (Iressa) in two patients.

Chang GC, Yang TY, Wang NS, Huang CM, Chiang CD. Chang GC, et al. J Formos Med Assoc. 2003 Jun;102(6):407-11. J Formos Med Assoc. 2003. PMID: 12923594

4

The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures.

Chang GC, Wu CL, Pan SH, Yang TY, Chin CS, Yang YC, Chiang CD. Chang GC, et al. Chest. 2004 Feb;125(2):541-7. doi: 10.1378/chest.125.2.541. Chest. 2004. PMID: 14769736

5

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status.

Chang GC, Chen KC, Yang TY, Yin MC, Lin CP, Kuo BI, Hsu JY. Chang GC, et al. Invest New Drugs. 2005 Jan;23(1):73-7. doi: 10.1023/B:DRUG.0000047108.39129.7c. Invest New Drugs. 2005. PMID: 15528983

6

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.

Chang GC, Yang TY, Chen KC, Yin MC, Wang RC, Lin YC. Chang GC, et al. J Clin Oncol. 2004 Nov 15;22(22):4646-8. doi: 10.1200/JCO.2004.02.168. J Clin Oncol. 2004. PMID: 15542815 No abstract available.

7

A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.

Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ. Chang GC, et al. Cancer. 2005 Feb 15;103(4):763-71. doi: 10.1002/cncr.20843. Cancer. 2005. PMID: 15637694 Free article.

8

The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.

Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, Chen JJ, Yang PC. Wang CC, et al. Among authors: chang gc. Oncogene. 2005 Jun 9;24(25):4081-93. doi: 10.1038/sj.onc.1208573. Oncogene. 2005. PMID: 15782117

9

Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines.

Chang JT, Chang GC, Ko JL, Liao HY, Liu HJ, Chen CC, Su JM, Lee H, Sheu GT. Chang JT, et al. Among authors: chang gc. Int J Cancer. 2006 Jan 15;118(2):317-25. doi: 10.1002/ijc.21372. Int J Cancer. 2006. PMID: 16080190

10

Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.

Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY. Shih CM, et al. Among authors: chang gc. Lung Cancer. 2006 Apr;52(1):15-20. doi: 10.1016/j.lungcan.2005.11.011. Epub 2006 Feb 14. Lung Cancer. 2006. PMID: 16476505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters